PEPE, ALESSIA
 Distribuzione geografica
Continente #
NA - Nord America 6.246
AS - Asia 5.992
EU - Europa 4.128
AF - Africa 2.045
SA - Sud America 1.936
OC - Oceania 214
Continente sconosciuto - Info sul continente non disponibili 112
Totale 20.673
Nazione #
US - Stati Uniti d'America 5.152
SG - Singapore 1.655
HK - Hong Kong 1.633
BR - Brasile 1.156
PL - Polonia 533
IT - Italia 418
VN - Vietnam 385
FR - Francia 357
CN - Cina 328
FI - Finlandia 264
RU - Federazione Russa 253
DE - Germania 211
AR - Argentina 138
AT - Austria 133
GB - Regno Unito 107
EC - Ecuador 100
TR - Turchia 99
IE - Irlanda 90
IN - India 87
MX - Messico 84
RS - Serbia 81
CO - Colombia 80
ZA - Sudafrica 80
UA - Ucraina 78
PY - Paraguay 77
AO - Angola 75
ID - Indonesia 75
SE - Svezia 74
NL - Olanda 73
TH - Thailandia 73
AE - Emirati Arabi Uniti 72
VE - Venezuela 72
LB - Libano 71
MA - Marocco 71
UZ - Uzbekistan 70
BO - Bolivia 69
KR - Corea 69
LV - Lettonia 69
MK - Macedonia 68
PA - Panama 68
PT - Portogallo 68
CL - Cile 67
TT - Trinidad e Tobago 67
BY - Bielorussia 66
NO - Norvegia 66
PE - Perù 66
CI - Costa d'Avorio 65
JO - Giordania 65
CR - Costa Rica 64
GT - Guatemala 64
HN - Honduras 64
EE - Estonia 63
HU - Ungheria 63
JM - Giamaica 63
LC - Santa Lucia 63
MD - Moldavia 63
SA - Arabia Saudita 63
SI - Slovenia 63
IQ - Iraq 62
AZ - Azerbaigian 61
BE - Belgio 61
RO - Romania 61
UG - Uganda 61
IR - Iran 60
BB - Barbados 59
GA - Gabon 59
HR - Croazia 59
PH - Filippine 59
EG - Egitto 58
DZ - Algeria 57
GF - Guiana Francese 57
GR - Grecia 57
IS - Islanda 57
SN - Senegal 57
BZ - Belize 56
CD - Congo 56
CW - ???statistics.table.value.countryCode.CW??? 56
KZ - Kazakistan 56
MZ - Mozambico 56
TJ - Tagikistan 56
TN - Tunisia 56
XK - ???statistics.table.value.countryCode.XK??? 56
DK - Danimarca 55
AD - Andorra 54
AL - Albania 54
BW - Botswana 54
CH - Svizzera 54
CY - Cipro 54
KE - Kenya 54
LY - Libia 54
UY - Uruguay 54
ZM - Zambia 54
ES - Italia 53
GN - Guinea 53
IL - Israele 53
LU - Lussemburgo 53
NP - Nepal 53
YE - Yemen 53
BA - Bosnia-Erzegovina 52
BF - Burkina Faso 52
Totale 18.167
Città #
Hong Kong 1.590
Singapore 739
Fairfield 732
Bytom 472
Boardman 399
Medford 354
Princeton 353
Ashburn 283
Des Moines 271
Houston 233
San Diego 218
Cambridge 216
Santa Clara 206
Helsinki 195
Wilmington 142
Beijing 138
Chandler 129
Ho Chi Minh City 129
Woodbridge 106
São Paulo 103
Seattle 92
Chicago 84
Hanoi 81
Padova 80
Dublin 77
Vienna 73
Luanda 69
Los Angeles 65
Panama City 64
Ann Arbor 63
Amman 62
Abidjan 61
Castries 60
Kampala 60
Baku 58
Tashkent 58
Dakar 57
Libreville 55
Riga 55
Andorra la Vella 53
Dushanbe 53
Lusaka 52
Bridgetown 51
Conakry 51
Tallinn 50
Ulan Bator 50
Willemstad 50
San José 49
Managua 48
Nouakchott 48
Antananarivo 47
Kigali 45
Minsk 45
Accra 44
Montevideo 44
New York 44
Nuremberg 44
Munich 43
Nairobi 43
Podgorica 42
Kinshasa 41
Lima 41
Phnom Penh 41
Vientiane 41
Buffalo 40
Guatemala City 40
Maputo 40
Reykjavik 40
Roxbury 40
Kingston 39
Kingstown 39
Noumea 39
Sanaa 39
Bishkek 38
Niamey 38
Cayenne 37
Hefei 37
London 37
Ouagadougou 37
Praia 37
Pristina 37
Tripoli 37
Chisinau 36
Gaborone 36
Havana 36
Nassau 36
Yerevan 36
Bamako 35
Cotonou 35
Djibouti 35
Lilongwe 35
Tbilisi 35
Turku 35
Zagreb 35
Dili 34
Guayaquil 34
Quito 34
Athens 33
Belgrade 33
Dar es Salaam 33
Totale 10.759
Nome #
Reference values of cardiac volumes, dimensions, and new functional parameters by MR: A multicenter, multivendor study 168
Left and right ventricular morphology, function and late gadolinium enhancement extent and localization change with different clinical presentation of acute myocarditis Data from the Italian multicenter study on MYocarditis (ITAMY) 149
Serum organ-specific anti-heart and anti-intercalated disk autoantibodies as new autoimmune markers of cardiac involvement in systemic sclerosis: Frequency, clinical and prognostic correlates 132
Diagnostic Accuracy of CT Texture Analysis in Adrenal Masses: A Systematic Review 127
Clinical Value and Prognostic Impact of Pericardial Involvement in Acute Myocarditis Data From the ITAMY 122
Nodal staging with MRI after neoadjuvant chemo-radiotherapy for locally advanced rectal cancer: a fast and reliable method 121
Could CT Radiomic Analysis of Benign Adrenal Incidentalomas Suggest the Need for Further Endocrinological Evaluation? 117
Overcoming the Boundaries of Heart Warm Ischemia in Donation After Circulatory Death: The Padua Case 116
Ischemic Heart DiseaseFrom Diagnosis to Treatment 108
Medical Radiology: Current Progress. 106
Longitudinal prospective comparison of pancreatic iron by magnetic resonance in thalassemia patients transfusion-dependent since early childhood treated with combination deferiprone-desferrioxamine vs deferiprone or deferasirox monotherapy 101
Multimodality Imaging in Restrictive Cardiomyopathies. An EACVI expert consensus document. In collaboration with the “Working Group on myocardial and pericardial diseases” of the European Society of Cardiology. Endorsed by the Indian Academy of echocardiography 100
CMR for myocardial iron overload quantification: calibration curve from the MIOT Network 93
Cardioprotection by gene therapy: A review paper on behalf of the Working Group on Drug Cardiotoxicity and Cardioprotection of the Italian Society of Cardiology 92
Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment 91
Early Detection of Myocardial Involvement in Thalassemia Intermedia Patients: Multiparametric Mapping by Magnetic Resonance Imaging 90
Clinical recommendations of cardiac magnetic resonance, Part II: inflammatory and congenital heart disease, cardiomyopathies and cardiac tumors: a position paper of the working group ‘Applicazioni della Risonanza Magnetica’ of the Italian Society of Cardiology 90
Atrial dimension reference values in healthy participants using the biplane/monoplane method for clinical and research use 89
A complication risk score to evaluate clinical severity of thalassaemia syndromes 89
A recommended practical approach to the management of anthracycline-based chemotherapy cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 88
Standards for conducting and reporting consensus and recommendation documents: European Society of Cardiovascular Radiology policy from the Guidelines Committee 86
Additional value of segmental parametric mapping by Cardiovascular Magnetic Resonance in competitive athletes 86
Clinical recommendations of cardiac magnetic resonance, Part I: ischemic and valvular heart disease: a position paper of the working group ‘Applicazioni della Risonanza Magnetica’ of the Italian Society of Cardiology 85
Tumor Diagnosis and Treatment: Imaging Assessment 84
A recommended practical approach to the management of target therapy and angiogenesis inhibitors cardiotoxicity: An opinion paper of the working group on drug cardiotoxicity and cardioprotection, Italian Society of Cardiology 84
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: Cardiovascular magnetic resonance and nuclear cardiology 83
Feasibility, reproducibility, and reliability for the T2* iron evaluation at 3 T in comparison with 1.5 T 82
Does Insulin Like Growth Factor-1 (IGF-1) Deficiency Have a “Protective” Role in the Development of Diabetic Retinopathy in Thalassamia Major Patients? 80
Cardiovascular imaging in the diagnosis and monitoring of cardiotoxicity: cardiovascular magnetic resonance and nuclear cardiology. 79
Absence of long-term incremental prognostic value of inducible wall motion abnormalities on dipyridamole stress CMR in patients with suspected or known coronary artery disease 78
Textbook outcome and nomogram-guided approaches for enhancing surgical success in elderly HCC patients: Deciphering the influence of sarcopenia 77
Effect of inversion-recovery fat suppression on hepatic R2* quantitation in transfusional siderosis 76
The prognostic role of CMR using global planimetric criteria in patients with excessive left ventricular trabeculation 76
Pancreatic Volume in Thalassemia: Determinants and Association with Alterations of Glucose Metabolism 75
Cardiac MR With Late Gadolinium Enhancement in Acute Myocarditis With Preserved Systolic Function: ITAMY Study 75
27) Different patterns of myocardial iron distribution by whole-heart T2* Magnetic Resonance as risk markers for heart complications in thalassemia major. 75
Myocardial iron overload by cardiovascular magnetic resonance native segmental T1 mapping: a sensitive approach that correlates with cardiac complications 75
National networking in rare diseases and reduction of cardiac burden in thalassemia major 75
Improving the Preclinical Models for the Study of Chemotherapy-Induced Cardiotoxicity. A Position Paper of the Italian Working Group on Drug Cardiotoxicity and Cardioprotection 74
Potential Benefits of Photon-Counting CT in Dental Imaging: A Narrative Review 73
Left ventricle remodeling in patients with β-thalassemia major. An emerging differential diagnosis with left ventricle noncompaction disease 73
Setting for “normal” serum ferritin levels in patients with transfusion‐dependent thalassemia: Our current strategy 72
Arterial hypertension in the female world: pathophysiology and therapy 71
Myocardial fibrosis by late gadolinium enhancement cardiac magnetic resonance and hepatitis C virus infection in thalassemia major patients 71
Myocardial T2 values at 1.5 T by a segmental approach with healthy aging and gender 71
Prospective CMR Survey in Children With Thalassemia Major: Insights From a National Network 71
The link of pancreatic iron with glucose metabolism and cardiac iron in thalassemia intermedia: A large, multicenter observational study 71
Take a look at the heart: Incidental detection of a right atrial thrombus during abdominal MR 70
From molecular mechanisms to clinical management of antineoplastic drug-induced cardiovascular toxicity: A translational overview 70
9) Cost-Utility Analysis of Three Iron Chelators Used in Monotherapy for the Treatment of Chronic Iron Overload in β-Thalassaemia Major Patients: An Italian Perspective 70
Myocardial T1 Values at 1.5 T: Normal Values for General Electric Scanners and Sex-Related Differences 70
Consensus on the assessment of systemic sclerosis–associated primary heart involvement: World Scleroderma Foundation/Heart Failure Association guidance on screening, diagnosis, and follow-up assessment 69
4) The impact of liver steatosis on the ability of serum ferritin levels to be predictive of liver iron concentration in non-transfusion-dependent thalassaemia patients 69
The additive prognostic value of end-systolic pressure-volume relation by stress CMR in patients with known or suspected coronary artery disease 68
Cardiac inflammation and fibrosis patterns in systemic sclerosis, evaluated by magnetic resonance imaging: An update 68
Advantages of Photon-Counting Detector CT in Aortic Imaging 68
Longitudinal follow-up of patients with thalassaemia intermedia who started transfusion therapy in adulthood: a cohort study 68
Risk of mortality from anemia and iron overload in nontransfusion-dependent β-thalassemia 68
The planimetric Grothoff's criteria by cardiac magnetic resonance can improve the specificity of left ventricular non-compaction diagnosis in thalassemia intermedia 67
Non-compact myocardium assessment by cardiac magnetic resonance: dependence on image analysis method. 67
Acquired Hypogonadotropic Hypogonadism (AHH) in Thalassaemia Major Patients: An Underdiagnosed Condition? 67
Early Detection of Cardiac Involvement in Systemic Sclerosis: The Added Value of Magnetic Resonance Imaging 67
Primary HBB gene mutation severity and long-term outcomes in a global cohort of β-thalassaemia 67
36) The use of appropriate calibration curves corrects for systematic differences in liver R2* values measured using different software packages 66
Non-compact myocardium assessment by cardiac magnetic resonance: dependence on image analysis method 66
Long-term sequential deferiprone and deferasirox therapy in transfusion-dependent thalassaemia patients: a prospective clinical trial 66
Prospective cardiac magnetic resonance imaging survey in myelodysplastic syndrome patients: insights from an Italian network 66
Prediction of cardiac complications for thalassemia major in the widespread cardiac magnetic resonance era: a prospective multicentre study by a multi-parametric approach 65
A robust method for assessment of iron overload in liver by magnetic resonance imaging. 65
Combined Brain-Heart Imaging in Takotsubo Syndrome: Towards a Holistic Patient Assessment 64
Diabetes And Glucose Metabolism In Thalassemia Major: An Update 64
Standardized T2* map of a normal human heart to correct T2* segmental artefacts; myocardial iron overload and fibrosis in thalassemia intermedia versus thalassemia major patients and electrocardiogram changes in thalassemia major patients 64
Cardiac R2* values are independent of the image analysis approach employed 64
Cardiovascular Magnetic Resonance Reveals Cardiac Inflammation and Fibrosis in Symptomatic Patients with Post-COVID-19 Syndrome: Findings from the INSPIRE-CMR Multicenter Study 63
Improved T2* assessment in liver iron overload by magnetic resonance imaging 63
Quantitative T2* magnetic resonance imaging for renal iron overload assessment: normal values by age and sex 63
Long-term sequential deferiprone-deferoxamine versus deferiprone alone for thalassaemia major patients: a randomized clinical trial 63
The close link of pancreatic iron with glucose metabolism and with cardiac complications in thalassemia major: A large, multicenter observational study 63
Combined brain-heart MRI identifies cardiac and white matter lesions in patients with systemic lupus erythematosus and/or antiphospholipid syndrome: A pilot study 62
Secondary solid cancer following hematopoietic cell transplantation in patients with thalassemia major 62
Study of Renal iron overload by T2* MRI in a large cohort of thalassemia major patients. 62
Cardiac magnetic resonance predicts ventricular arrhythmias in scleroderma: The Scleroderma Arrhythmia Clinical Utility Study (SAnCtUS) 62
Oxidative Stress and Antioxidant Status in Adult Patients with Transfusion-Dependent Thalassemia: Correlation with Demographic, Laboratory, and Clinical Biomarkers 61
Improvement of heart iron with preserved patterns of iron store by CMR-guided chelation therapy 61
Pancreatic iron overload by T2* MRI in a large cohort of well treated thalassemia major patients: can it tell us heart iron distribution and function? 61
Detection of myocardial iron overload by two-dimensional speckle tracking in patients with beta-thalassaemia major: a combined echocardiographic and T2* segmental CMR study 61
Gender differences in the development of cardiac complications: a multicentre study in a large cohort of thalassaemia major patients to optimize the timing of cardiac follow-up. 61
Preferential patterns of myocardial iron overload by multislice multiecho T*2 CMR in thalassemia major patients 61
Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients 61
Multiparametric Cardiac Magnetic Resonance Survey in Children With Thalassemia Major: A Multicenter Study 61
Prevalence and prognostic impact of nonischemic late gadolinium enhancement in stress cardiac magnetic resonance 61
MRI multicentre prospective survey in thalassaemia major patients treated with deferasirox versus deferiprone and desferrioxamine 61
Heart T2* for Prediction of Cardiac Complications in well-treated TM patients 61
Cardiac iron and cardiac disease in males and females with transfusion-dependent thalassemia major: a T2* magnetic resonance imaging study 60
Pulmonary hypertension in well-transfused thalassemia major patients 60
Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron 60
Cardiovascular magnetic resonance in rheumatology: Current status and recommendations for use 60
Absence of T1 Hyperintensity in the Brain of High-risk Patients After Multiple Administrations of High-dose Gadobutrol for Cardiac Magnetic Resonance 60
Multicenter validation of the magnetic resonance T2* technique for quantification of pancreatic iron 60
Impact of the COVID-19 Pandemic on Iron Overload Assessment by MRI in Patients with Hemoglobinopathies: The E-MIOT Network Experience 60
Totale 7.664
Categoria #
all - tutte 85.968
article - articoli 69.349
book - libri 316
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.293
Totale 156.926


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202165 0 0 0 6 1 1 2 9 8 10 9 19
2021/20222.806 0 4 20 8 948 67 61 224 616 29 106 723
2022/2023974 603 17 5 24 55 83 0 37 52 28 59 11
2023/2024870 16 56 52 41 59 50 49 56 44 15 253 179
2024/20256.352 30 300 444 60 591 108 256 519 863 364 1.143 1.674
2025/20269.862 660 2.405 4.543 2.254 0 0 0 0 0 0 0 0
Totale 21.140